(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) jumped by a staggering 11.52% to $5.57 at 10:45 EST on Friday, after two sequential sessions in a row of gains. NASDAQ is jumping 2.9% to $11,700.17, following the last session’s upward trend. This seems, up until now, an all-around bullish trend trading session today.

Pacific Biosciences of California’s last close was $4.99, 86.28% below its 52-week high of $36.36.

Volume

Today’s last reported volume for Pacific Biosciences of California is 2126243 which is 66.46% below its average volume of 6340511.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 33.8% for the ongoing quarter and 48.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 178.4% and positive 40% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.59%, a negative 2.73%, and a positive 5.65%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 9.49% (last week), 5.88% (last month), and 5.65% (last quarter), respectively.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.57 at 10:45 EST, below its 52-week low of $5.70.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $8.98 and way under its 200-day moving average of $19.43.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here